IRIS
DONADIO, ELEONORA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 82
EU - Europa 67
AS - Asia 21
Totale 170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 81
SE - Svezia 26
IE - Irlanda 24
CN - Cina 20
IT - Italia 10
DE - Germania 5
FI - Finlandia 2
CA - Canada 1
IN - India 1
Totale 170
Salva come PNG Salva come JPEG
Città #
Chandler 39
Dublin 24
Beijing 12
Parma 7
Ann Arbor 4
Ashburn 4
Bremen 4
Princeton 4
Shanghai 4
Des Moines 2
Helsinki 2
Los Angeles 2
Wilmington 2
Fairfield 1
Pune 1
Redwood City 1
Rockville 1
Taiyuan 1
Toronto 1
Woodbridge 1
Totale 117
Salva come PNG Salva come JPEG
Nome #
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 51
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients 50
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 43
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 30
Totale 174
Salva come PNG Salva come JPEG
Categoria #
all - tutte 763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 763
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 0 0 20 5 0
2020/20219 0 0 0 1 3 2 1 1 0 0 1 0
2021/202214 0 0 1 2 0 0 0 0 2 1 1 7
2022/2023106 11 15 6 10 11 12 2 8 26 0 1 4
2023/202420 1 3 0 1 2 4 3 2 2 2 0 0
Totale 174